Clinical Research
Advancing Patient Care
Stanford Hematology’s Clinical Research program is dedicated to advancing patient care through innovative trials and studies. We design and conduct cutting-edge clinical trials that test new therapies, improve treatment strategies, and bring scientific discoveries directly to patients with blood disorders. Our mission is to translate research into real-world impact, offering patients access to the latest treatments while driving progress in hematology.
Caroline Berube
Dr. Berube is involved in research in the field of congenital bleeding disorders, specifically in the development of gene therapy for patients with hemophilia. She is also a collaborator in research looking at the treatment of anemia during pregnancy, and its impact on maternal and perinatal outcomes.
Ami Bhatt
Dr. Bhatt’s lab has conducted extensive sample collection efforts at Stanford and beyond, gathering stool, blood, and saliva from patients. These samples represent a range of diseases, including blood cancers, Parkinson’s disease, and inflammatory bowel disease (IBD). Using data derived from these biospecimens, the Bhatt lab develops and tests hypotheses about microbiome-mediated mechanisms that may contribute to disease pathology.
May Chien
Dr. Chien is leading gene therapy efforts for sickle cell disease at Stanford and is dedicated to advancing novel therapies for patients with inherited and acquired hematologic conditions. Her clinical and research interests focus on sickle cell disease, thalassemia, and other red blood cell disorders, along with bleeding disorders and thrombosis
Robert Diep
Dr. Diep’s clinical research focuses on thrombosis and anticoagulation within nonmalignant hematology, with current investigations into novel therapeutics for conditions such as heparin-induced thrombocytopenia and warm autoimmune hemolytic anemia.
Bita Fakhri
Dr. Fakhri’s clinical focus includes chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and Richter’s transformation.
Jason Gotlib
Dr. Gotlib’s clinical focus is myeloproliferative neoplasms (MPN), including chronic myeloid leukemia, polycythemia vera, essential thrombocythemia, myelofibrosis, systemic mastocytosis, and eosinophilic neoplasms. He also treats myelodysplastic syndromes (MDS), and overlaps MDS/MPN disorders.
Peter Greenberg
Dr. Greenberg’s clinical focus includes myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and clonal hematopoiesis. His current investigations include evaluation of the impact of molecular taxonomic features and polymorphisms of myeloid neoplasms on treatment response and clinical outcomes. He coordinates an interdepartmental project on therapeutic drug discovery and directs several clinical trials for these disorders.
David Iberri
Dr. Iberri’s clinical focus includes multiple myeloma, Waldenström macroglobulinemia, and monoclonal gammopathy of clinical significance. His research centers on improving the accuracy of monoclonal gammopathy diagnosis and monitoring patients with myeloma using mass spectrometry.
Calvin Kuo
Dr. Kuo’s work translates cutting-edge science into clinical advances, focusing on developing targeted therapies for cancer using organoid models, advancing regenerative treatments through stem cell research, and creating vessel-targeted strategies for stroke and tumor patients. His research directly informs new approaches in patient care and clinical treatment development.
Michaela Liedtke
Dr. Liedtke’s clinical research involves developing and evaluating novel therapies for lymphoid malignancies with a focus on acute lymphoblastic leukemia and plasma cell disorders - particularly multiple myeloma and AL (light chain) amyloidosis - including CAR-T cell approaches and antibodies targeting amyloid fibrils.
Gabriel Mannis
Dr. Mannis’s clinical work centers on the care of patients with acute myeloid leukemia, high-risk myelodysplastic syndromes (MDS), and blastic plasmacytoid dendritic cell neoplasm (BPDCN), with a focus on advancing treatment options for these high-risk blood cancers.
Ann Mullally
Dr. Mullally’s research interest is myeloproliferative neoplasms (MPN). She is actively involved in all aspects of patient-oriented research and sees patients in her MPN clinic. She works closely with Drs. Gotlib and Shomali to help advance the treatment of MPN by using genomic, single-cell and biological research studies to gain a deeper understanding of MPN biology and translate this into better outcomes for patients.
Giselle Salmasi
Dr. Salmasi’s clinical focus includes immune thrombocytopenia (ITP), warm autoimmune hemolytic anemia (wAIHA), cold agglutinin disease, thrombosis, and iron disorders.
Tait Shanafelt
Dr. Shanafelt’s clinical focus includes chronic lymphocytic leukemia (CLL), hairy cell leukemia, and large granular lymphocytic (T-cell LGL) leukemia.
William Shomali
Dr. Shomali’s clinical focus includes myeloproliferative neoplasms, myelodysplastic syndromes, systemic mastocytosis, and acute lymphoblastic leukemia. His research interests include the study of novel agents in those disorders.
Tian Zhang
Dr. Zhang’s clinical expertise is in myeloid hematologic malignancies, with a focus on acute myeloid leukemia, myelodysplastic syndromes, clonal hematopoiesis, and therapy-related myeloid neoplasms.
